---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-052962"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:45:55.822593+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nutex Health H1 2025 revenue $455.8M (+217.5% YoY), net income $3.5M, launches $25M buyback

## Summary
- H1 2025 revenue $455.8M (+217.5% YoY); net income $3.5M vs net loss $0.7M in H1 2024.
- Diluted EPS $0.55 (H1 2025) vs $(0.15); Adjusted EBITDA $144.4M vs $6.4M YoY.
- Q2 2025 revenue $244.0M (+220.7% YoY); net loss $17.7M includes $78.7M non-cash stock-based comp.
- Board authorized $25M stock repurchase program on Aug 14, 2025 to offset dilution.
- Net cash from operations $78.2M H1; cash balance $96.7M at June 30, 2025.

## SEC filing metadata
- accession: 0001628280-25-052962
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052962/0001628280-25-052962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000162828025052962/nutx-20251118.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-052962
- JSON: https://secwatch.observer/filing/0001628280-25-052962.json
- Plain text: https://secwatch.observer/filing/0001628280-25-052962.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.